Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis.
about
Separate and overlapping specificities in rheumatoid arthritis antibodies binding to citrulline- and homocitrulline-containing peptides related to type I and II collagen telopeptidesBiologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysisSubcutaneous or intramuscular methotrexate for rheumatoid arthritisTocilizumab for rheumatoid arthritisTocilizumab for rheumatoid arthritisBiologics for rheumatoid arthritis: an overview of Cochrane reviewsBiologics for rheumatoid arthritis: an overview of Cochrane reviewsGolimumab for rheumatoid arthritisAnakinra for rheumatoid arthritisAnakinra for rheumatoid arthritisEvidence for early disease-modifying drugs in rheumatoid arthritisEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 updateCombination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single componentsTreatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazineBiologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.Missing radiographic data handling in randomized clinical trials in rheumatoid arthritis.Insights into rheumatoid arthritis from use of MRI.Interpreting radiographic data in rheumatoid arthritis.Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis.Presentation and analysis of data on radiographic outcome in clinical trials: experience from the TEMPO study.One-year maintenance with routine assessment of patient index data 3-based remission may inhibit radiographic progression in patients with rheumatoid arthritis treated with routine clinical therapy: A retrospective comparison of radiographic outcomeFlexor Hallucis Longus tendon rupture in RA-patients is associated with MTP 1 damage and pes planus.The clinical application of etanercept in Chinese patients with rheumatic diseases.Evidence for predictive validity of remission on long-term outcome in rheumatoid arthritis: a systematic review.Slow drugs: slow progress? Use of slow acting antirheumatic drugs (SAARDs) in rheumatoid arthritisCirculating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine.A T cell receptor beta chain variable region polymorphism associated with radiographic progression in rheumatoid arthritis.Second line (disease modifying) treatment in rheumatoid arthritis: which drug for which patient?Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis.Should patients with recent onset rheumatoid arthritis be offered genetic screening?Relationship between time-integrated disease activity estimated by DAS28-CRP and radiographic progression of anatomical damage in patients with early rheumatoid arthritis.Time-averaged disease activity fits better joint destruction in rheumatoid arthritis.Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis.Association of IL4R single-nucleotide polymorphisms with rheumatoid nodules in African Americans with rheumatoid arthritis.Anti-TNF agents for rheumatoid arthritis.Early rheumatoid arthritis: can we predict its outcome?Radiographic scoring methods as outcome measures in rheumatoid arthritis: properties and advantages.Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy.Disease modifying drugs for rheumatoid arthritis: yesterday's treatment today or today's treatment tomorrow?
P2860
Q21146625-4609947E-555D-4145-B1A8-0C6392685047Q24185797-C3768B13-8D42-48D8-9293-AF6C7189A157Q24187565-962AECC6-B8BA-4F5F-9773-329915747D98Q24234126-F6DF53E9-5586-482E-A21C-F1636787FEDEQ24239949-872828B0-F63E-4D1E-AC3D-F9A8505A6975Q24240731-1D9A9F28-8FCF-46D4-BDB2-71B3DD2F999EQ24240891-172E0003-9E23-415A-8F68-A8D82E292449Q24240895-950A1380-BE72-4268-B5CA-78FDCB3FF45DQ24241707-A1E67F94-CC09-4E17-B4CF-171C87BF6B6DQ24243387-8D55580C-C256-4BFF-914C-2082BE388081Q24793240-8F17E5CE-6734-477B-90CF-DA8B9908FB27Q26859134-AC4DCDC1-478B-4883-BAB2-D2DCDB6C3AF1Q28343376-865558D0-3382-41D9-8777-8DB6B63396DFQ28353468-C728C802-F43A-4934-A340-E805302AC89BQ30234528-4620E9AF-9FC0-4B02-9CD9-54354A7A7DECQ30235341-ED9BE79C-C98C-4C49-8346-1524FC16E875Q30679899-229E7230-15A1-4DDC-8BD3-A3D33B2E8CDFQ30698398-CE957BC9-3488-4E8E-807A-0A49C2588335Q30804224-2472A00F-1ED1-4533-A849-F62C8B0F127BQ30836381-EDF15464-3055-4713-B696-57E6E80D64B2Q30980061-FCDC9669-F6B0-42C3-943A-5C452A44FA12Q31049240-2F3D07CA-AB23-4588-98A7-81C683C79BE2Q33305158-9D76697D-1CFE-4AC6-8F07-978100855BC5Q33372242-606262BF-45E7-4B64-86A3-23A5CDB2C540Q33535269-137F8AF9-9EDE-422A-813A-1276E5FB6F89Q33564477-E32D6894-968C-4469-8D15-8E97CE09B509Q33564938-3EC323FA-A4B3-4501-8463-3A606511B3B6Q33565430-A8163B54-ABF3-44DB-AC15-48AE11FE7413Q33565496-D1632467-94EE-401E-A60D-8AF6E7F16632Q33567430-F7075284-7A3E-4022-BEC6-185F136E808AQ33579027-CA810477-5CB7-40BC-8B85-BD76DA9D6608Q33915665-D88E68CC-DFD5-4DFC-83D2-6B9B3C9041BCQ33918379-2BC26ABD-E6B5-4791-AF50-EB82BCA86D4DQ33954663-92BC76B3-8380-4F54-8F09-A16FCF6FED2CQ34027406-8924B709-3FD6-4F59-A549-619770177ECEQ34216181-604D115B-B113-484B-A7D3-CA793F85ECD0Q34322390-C2401AB1-91CC-4B50-BCAA-DC33A6421B8CQ34335747-34F8F31E-66A9-4A70-825F-9295D65ED1CDQ34343286-064F6ABA-3237-45DC-934A-672BC23D7B01Q34357618-015E5A64-BED9-4D23-8F4B-9A1B3F02D1BA
P2860
Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Effects of hydroxychloroquine ...... amage in rheumatoid arthritis.
@en
type
label
Effects of hydroxychloroquine ...... amage in rheumatoid arthritis.
@en
prefLabel
Effects of hydroxychloroquine ...... amage in rheumatoid arthritis.
@en
P2093
P1433
P1476
Effects of hydroxychloroquine ...... amage in rheumatoid arthritis.
@en
P2093
D M van der Heijde
F W Gribnau
I H Nuver-Zwart
L B vad de Putte
P L van Riel
P304
P356
10.1016/S0140-6736(89)92442-2
P407
P577
1989-05-01T00:00:00Z